381301

Human Leukocyte Antigen – DR (HLA-DR) Isotype Expression on Monocytes as a Prognostic Marker in Patients with Sepsis in Intensive Care Unit

Article

Last updated: 07 Jan 2025

Subjects

-

Tags

Diagnostics

Abstract

Background: Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis begins with excessive inflammatory state caused by pro-inflammatory cytokines which can be followed by Immunosuppression state. During the immune paralysis stage, the level of Human Leukocyte antigen -DR (HLA-DR) expression on monocytes is decreased which increase the risk of secondary infection. Objective: This study aims to evaluate the relation between the level of Human Leukocyte Antigen DR expressed on monocytes (mHLA-DR) and the clinical outcome of septic patients to use mHLA-DR as a prognostic marker for Sepsis. Methodology: Blood samples were withdrawn from 40 patients diagnosed as sepsis in Intensive Care Units in El Demerdash Hospital and 20 apparently healthy individuals. Flowcytometric analysis was used to measure the level of HLA-DR expressed on monocytes. A second sample was taken from each patient after 1 week. For long hospitalized patients, a third sample was taken after 1 more week to follow up the level of mHLA-DR. Results: Percentage of mHLA-DR in the initial sample, First and second follow up samples (median=76.5%) showed highly significant difference compared to the sample taken from control group (median=99.1%). No significant difference was found in mHLA-DR percentage between initial sample (median=76.5%), first follow up sample (median=76.55%), second follow up sample (median=55.6%). There was no statistically significant difference in the percentage of mHLA-DR in the three samples between died and alive patients. Conclusion: The level of mHLA-DR can be used as a predictive biomarker for the clinical outcome of patients with sepsis.

DOI

10.21608/ejmm.2024.318701.1331

Keywords

Keywords: Sepsis, Immune paralysis, Human Leukocyte Antigen-DR (HLA-DR), total leukocytic count

Authors

First Name

Nada

Last Name

Sadek

MiddleName

A.

Affiliation

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University

Email

nadaashraf1215@gmail.com

City

-

Orcid

-

First Name

Ayman

Last Name

Ebrahim

MiddleName

A.

Affiliation

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University

Email

draymanasaad@yahoo.com

City

Cairo

Orcid

-

First Name

Amr

Last Name

Hamza

MiddleName

H.

Affiliation

Anesthesia and Intensive Care Unit Department, Faculty of Medicine, Ain Shams University, Egypt

Email

amrhosny888@gmail.com

City

cairo

Orcid

-

First Name

Fatma

Last Name

Mahmoud

MiddleName

M.

Affiliation

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University

Email

fatma_mostafa@med.asu.edu.eg

City

cairo

Orcid

-

Volume

34

Article Issue

1

Related Issue

50252

Issue Date

2025-01-01

Receive Date

2024-09-07

Publish Date

2025-01-01

Page Start

55

Page End

63

Print ISSN

1110-2179

Online ISSN

2537-0979

Link

https://ejmm.journals.ekb.eg/article_381301.html

Detail API

http://journals.ekb.eg?_action=service&article_code=381301

Order

7

Type

New and original researches in the field of Microbiology.

Type Code

2,038

Publication Type

Journal

Publication Title

Egyptian Journal of Medical Microbiology

Publication Link

https://ejmm.journals.ekb.eg/

MainTitle

Human Leukocyte Antigen – DR (HLA-DR) Isotype Expression on Monocytes as a Prognostic Marker in Patients with Sepsis in Intensive Care Unit

Details

Type

Article

Created At

28 Dec 2024